Global Cytomegalovirus IgM Detection Kit Market Growth 2025-2031

The global Cytomegalovirus IgM Detection Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Cytomegalovirus IgM Detection Kit is used for the detection of human antibodies in serum or plasma directed against Cytomegalovirus. Cytomegalovirus is a herpes virus. It is a leading etiological agent for congenital abnormalities and complications among those who receive massive blood transfusions and immunosuppressive therapy. About half of pregnant women who contract a primary infection spread the disease to their fetus. Infection during pregnancy may cause mental retardation, blindness, and/or deafness of the fetus. Cytomegalovirus infection is very common in the population, but most of them are subclinical recessive and latent infections. When the infected person is immunocompromised or pregnant, receiving immunosuppressant treatment, organ transplantation, or suffering from tumors, the virus can be activated and cause clinical symptoms. After human cytomegalovirus infects pregnant women, the virus infects the fetus through the placenta, causing intrauterine infection. Therefore, the detection of CMV-IgM antibody is of great significance for understanding the situation of human cytomegalovirus infection in women of childbearing age, early diagnosis of congenital human cytomegalovirus infection and prevention of birth of children with congenital infection.

United States market for Cytomegalovirus IgM Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cytomegalovirus IgM Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cytomegalovirus IgM Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cytomegalovirus IgM Detection Kit players cover Abcam, Accubiotech, BioMerieux, SA, Boster Bio, CTK Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Cytomegalovirus IgM Detection Kit Industry Forecast” looks at past sales and reviews total world Cytomegalovirus IgM Detection Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Cytomegalovirus IgM Detection Kit sales for 2025 through 2031. With Cytomegalovirus IgM Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cytomegalovirus IgM Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global Cytomegalovirus IgM Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cytomegalovirus IgM Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cytomegalovirus IgM Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cytomegalovirus IgM Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cytomegalovirus IgM Detection Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Cytomegalovirus IgM Detection Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Enzyme-Linked Immunosorbent Assay(ELISA)

Colloidal Gold Method

Others

Segmentation by Application:

Clinic

Hospital

Laboratory

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Abcam

Accubiotech

BioMerieux, SA

Boster Bio

CTK Biotech

Diagnostic Automation / Cortez Diagnostics

Lifespan Biosciences

QED Bioscience

ZEUS Scientific

Beijing North Institute of Biotechnology

Wantai BioPharm

Innovita Biological Technology

TZYBIOTECH

Zhousi.biz

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cytomegalovirus IgM Detection Kit market?

What factors are driving Cytomegalovirus IgM Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cytomegalovirus IgM Detection Kit market opportunities vary by end market size?

How does Cytomegalovirus IgM Detection Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.